Quick Answer
Silo Pharma, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.75 million for the year ending 2025.
- Silo Pharma, Inc. showed an increase of +21.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Silo Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $0.00 | Q3 2010: $8.1 thousand | Q1 2011: $36.2 thousand | Q2 2011: $25.8 thousand | Q3 2011: $8.1 thousand | Q1 2012: $3.7 thousand | Q2 2012: $813.00 | Q3 2012: $279.00 | Q1 2013: $10.1 thousand | Q2 2013: $368.7 thousand | Q3 2013: $1.26 million | Q3 2017: $301.7 thousand | Q1 2018: $486.3 thousand | Q2 2018: $776.2 thousand | Q3 2018: $626.1 thousand | Q1 2019: $177.3 thousand | Q2 2019: $77.0 thousand | Q3 2019: $24.6 thousand | Q4 2019: $111.8 thousand | Q1 2020: $9.1 thousand | Q2 2020: $1.92 million | Q3 2020: $1.65 million | Q1 2021: $4.64 million | Q2 2021: $4.15 million | Q3 2021: $10.26 million | Q1 2022: $9.07 million | Q2 2022: $8.73 million | Q3 2022: $12.25 million | Q1 2023: $4.67 million | Q2 2023: $158.8 thousand | Q3 2023: $199.8 thousand | Q1 2024: $2.67 million | Q2 2024: $4.51 million | Q3 2024: $4.86 million | Q1 2025: $3.14 million | Q2 2025: $4.33 million | Q3 2025: $3.92 million.
- Historical annual values: Fiscal year 2025: $4.75 million | Fiscal year 2024: $3.91 million | Fiscal year 2023: $3.52 million | Fiscal year 2022: $11.37 million | Fiscal year 2021: $9.84 million | Fiscal year 2020: $1.13 million | Fiscal year 2019: $111.8 thousand | Fiscal year 2018: $336.7 thousand | Fiscal year 2017: $294.6 thousand | Fiscal year 2016: $579.2 thousand | Fiscal year 2013: $2.01 million | Fiscal year 2012: $279.00 | Fiscal year 2011: $1.8 thousand | Fiscal year 2010: $47.5 thousand | Fiscal year 2010: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: